Penn Researchers ID Acetylated Tau as Potential Protein Biomarker for Alzheimer's, Related Disorders

Their findings suggest that acetylated tau might be a useful addition to more established AD biomarkers like amyloid-beta, tau, and phosphorylated tau and could help clinicians distinguish between various forms of frontotemporal lobar degeneration.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.